Home » Topics » Regulatory » Patents

Patents
RSS

New 5-HT4 and/or H3 receptor ligands designed at Synthelabo

Dec. 28, 1998

Somatostatin agonists from Takeda claimed for diabetes and its complications

Dec. 23, 1998

Patent assigned to Sumitomo describes new compounds for immune and inflammatory disorders

Dec. 23, 1998

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

New series of 5-ht1F agonists disclosed by Lilly

Dec. 23, 1998

New cell adhesion inhibitors in development at Lilly for inflammatory disorders, etc.

Dec. 22, 1998

SmithKline Beecham patents combined 5-HT1A/5-HT1B/5-HT1D receptor antagonists

Dec. 22, 1998

Orally bioavailable serine protease inhibitors for thrombotic disorders designed at Akzo

Dec. 22, 1998

Another group of MMP inhibitors discovered at Hoechst

Dec. 22, 1998

5'-Deoxycytidines improve delivery to tumors and antineoplastic activity of 5-FU

Dec. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...